Introduction
Northern Nigeria is part of the meningitis belt, an area that in large part consists of the Sahel (Fig. 1) . In 1996 northern Nigeria was struck once again by a meningitis epidemic, the worst in 30 years, caused by Neisseria meningitidis serogroup A. In January and February 1996, when the news of the epidemic reached the outside world, there were already 7000 cases registered, with a case fatality rate (CFR) of >20%. An international alarm was sounded and Medecins sans Frontieres (MSF) sent an exploratory team to the area by mid-February 1996. The Nigerian government was already vaccinating direct contacts of cases and conducting mass immunization in schools and military bases. The government welcomed the MSF assistance. Within 3 weeks, 40 MSF staff had arrived, and later this was increased to 90 individuals. During this epidemic, which lasted from November 1995 to May 1996, a total of 75000 meningitis cases were registered, of which 8440 died (CFR, 11%) (1) . MSF assistance was limited to three northern states (Bauchi, Kano, and Katsina). The population of these three states is 14 million and 75 % of all the meningitis cases in the 1996 outbreak occurred there. In the course of the intervention, Nigerian health staff vaccinated 5.1 million people, 2.9 million of whom were vaccinated with the support of MSF. Furthermore, 56700 cases of meningitis were treated, 30000 with the support of MSF. The costs of the aid delivered by MSF totalled US$ 2.935 million.
This article describes the course of the epidemic and the assistance given by MSF in one of the three states, Katsina (population, 4.5 million) (2) . It analyses the impact of this assistance and ends with recommendations for future interventions during meningitis epidemics in sub-Saharan Africa.
Results
Description of the epidemic and the assistance given The course of the epidemic in Katsina (Fig. 2) showed an initial phase with a gradual increase, a second phase with a sharp increase, and a final phase with an abrupt end.
Cases (defined as individuals presenting with fever, headache, and stiff neck) were first reported in Fig. 1 Fig. 3 . Before the MSF assistance, the CFR in Katsina was, on average, 17%; after the start of the intervention the CFR quickly decreased to approximately 8% (Fig. 4) (Fig. 4) , but also the number of reported deaths from meningitis decreased dramatically (Fig. 3) . This absolute reduction in reported deaths is probably an underestimate due to incomplete reporting of deaths before the intervention. Therefore, the reduction of the CFR may largely be attributed to the intervention. (8) shows that if the vaccination campaign starts as soon as the epidemic threshold is passed, the number of prevented cases is five times greater than if the campaign begins at the peak of the epidemic.
Although the proportion of prevented meningitis cases as a result of MSF support to the vaccination campaign for the entire Katsina State was calculated to be 3.3% per district, this proportion varied from 2% to 17%. Analysis at the district level shows that the timing of the vaccination campaign relative to the threshold (time elapsed between the threshold and the start of the campaign) is more important than the timing relative to the peak of the epidemic (before, during, or after the peak incidence) ( Table  2 ). This arises because in most cases the epidemic curve is asymmetrical, with the peak occurring late in the epidemic. Most meningitis cases occur before the peak incidence. Thus, the earlier that vaccination starts after passing the epidemic threshold, the greater will be the effect on the number of cases prevented.
In Katsina, where vaccination was carried out in 13 of the total 26 districts, only two did so before the peak and only two were within 6 weeks of passing the epidemic threshold. These data speak for themselves. It should be borne in mind, however, that in retrospect it is simple to determine that vaccination As is the case in previous studies (9), our epidemiological data did not reveal a clear relationship between the size of villages and the attack rate. The epidemic foci were not uniformly distributed among the villages in the affected areas and research was needed to locate where most cases were occurring in Katsina State. Finally, vaccination should be restricted to the population most affected by the epidemic: those aged 6 months to 30 years. In reality this is not always possible since during a meningitis epidemic everyone demands to be vaccinated.
It has been suggested that in high-risk countries meningitis vaccination should be included in the Expanded Programme on Immunization (EPI) as the cheapest and most efficient solution. In general, EPI attains high vaccination coverage. The short duration of protection afforded by meningitis vaccine, however, requires revaccination every 3 years until 30 years of age in order to maintain effective immunity among the population. In young children, for whom seroconversion is low and the duration of pro-tection is <1 year, an even higher vaccination frequency would be required (10).
Conclusions
It is tempting to attribute the end of the epidemic to the coordinated effort of MSF and the Nigerian government (treatment with chloramphenicol, surveillance, training and mass vaccination). We calculated that the impact of the mass vaccination campaign was marginal. In most districts the epidemic had progressed too far or was even in decline when vaccination commenced, and only 3.3% of cases were prevented by vaccination. Other factors such as the onset of the rainy season and herd immunity (the number of people who develop a natural immunity after contact with the disease) probably played a crucial role in ending the epidemic (11) .
In view of the rapidity of the epidemic and the relatively late access that MSF had to the affected areas, it would have been better not to vaccinate from a cost-effectiveness perspective. In practice, however, this option is not realistic since pressure to vaccinate is great from governmental and international organizations. Also, vaccination is often a precondition for gaining access to implement curative activities. Therefore, a strict, more selective vaccination strategy is an effective option: vaccinate only in those districts where it is clear that it will still have a significant protective effect. Mass vaccination against meningitis is effective only if it is conducted within 4-6 weeks after passing the epidemic threshold (>15 cases per 100000 population per week). A functioning early warning and surveillance system is an absolute precondition for this. Only on the basis of timely and reliable information is it possible to develop effective vaccination strategies. Surveillance must occur at the level of the small administrative unit (3), since the epidemic threshold at the level of large administrative units (population >100000) will occur too late. In most African countries in the meningitis belt surveillance systems function poorly or not at all because of the increasing financial and logistic constraints that these countries face. In Nigeria MSF has started a cooperative programme with the ministry of health to strengthen local capacity for early recognition of epidemics (not only meningitis but also cholera, measles, yellow fever, etc.).
Treatment of meningitis patients in the present study was effective: at least 900 deaths were prevented in Katsina, a mortality reduction of at least 36%. During L' analyse au niveau du district montre que la chronologie de la campagne de vaccination par rapport au seuil 6pid6mique (temps 6coul6 entre le franchissement du seuil et le d6but de la campagne) est plus importante que par rapport au pic de l'6pid6mie. Une fois le seuil 6pid6mique pass6, plus la vaccination est pratiqu6e t6t, plus l'effet sur le nombre de cas evit6s sera sensible.
Dans la plupart des districts 6tudi6s, 1'6pid6mie 6tait d6ja trop avanc6e ou avait meme commence a d6cliner lorsque la vaccination a commenc6. Une strat6gie vaccinale plus selective est donc une option efficace: il ne faut vacciner que dans les districts ou il est certain que la vaccination aura encore un effet protecteur significatif. La vaccination de masse n'est efficace que si elle est pratiqu6e 4 a 6 semaines apres le franchissement du seuil 6pid6mique. Pour d6terminer ce moment, il est absolument indispensable de disposer d'un systeme operationnel de surveillance et d'alerte precoce.
Le traitement des malades a ete efficace: au moins 900 d6ces ont et6 6vit6s dans l'Etat de Katsina, soit une r6duction de la mortalit6 d'au moins 36%. Pendant les 6pid6mies de meningite dans les pays oO les systemes de surveillance sont insuffisants, comme c'est le cas dans la plupart des pays d'Afrique subsaharienne.
